ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 163.30% | -292.63% | -28.13% | -78.87% | -1,239.09% |
Total Depreciation and Amortization | -6.53% | -59.44% | 31.62% | 16.90% | 24.55% |
Total Amortization of Deferred Charges | 165.71% | 1,302.86% | 1,067.92% | 879.17% | 600.00% |
Total Other Non-Cash Items | -29,475.00% | 732.33% | -34.91% | -48.50% | -97.89% |
Change in Net Operating Assets | -201.33% | 273.79% | 50.56% | 78.52% | 71.10% |
Cash from Operations | 34.22% | -371.45% | 13.41% | 30.75% | -1,179.83% |
Capital Expenditure | -- | 168.20% | 73.65% | 96.06% | -67.70% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -75.77% | 81.05% | -100.00% | -100.00% | 155.77% |
Cash from Investing | -64.97% | 96.84% | -129.22% | -89.79% | 247.40% |
Total Debt Issued | -91.71% | -- | -- | -- | -67.63% |
Total Debt Repaid | -715.68% | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -775.00% | -- | -- | -- | -- |
Cash from Financing | -14.66% | 27.74% | 138.00% | 11,425.53% | 35.18% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -35.94% | -84.01% | 59.29% | 110.87% | -186.11% |